Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients.

Bolis M, Terao M, Pattini L, Garattini E, Fratelli M.

Blood Cancer J. 2019 Sep 30;9(10):76. doi: 10.1038/s41408-019-0241-5. No abstract available.

2.

Influenza Vaccination Induces NK-Cell-Mediated Type-II IFN Response that Regulates Humoral Immunity in an IL-6-Dependent Manner.

Farsakoglu Y, Palomino-Segura M, Latino I, Zanaga S, Chatziandreou N, Pizzagalli DU, Rinaldi A, Bolis M, Sallusto F, Stein JV, Gonzalez SF.

Cell Rep. 2019 Feb 26;26(9):2307-2315.e5. doi: 10.1016/j.celrep.2019.01.104.

3.

HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.

Paroni G, Bolis M, Zanetti A, Ubezio P, Helin K, Staller P, Gerlach LO, Fratelli M, Neve RM, Terao M, Garattini E.

Oncogene. 2019 Apr;38(15):2675-2689. doi: 10.1038/s41388-018-0620-6. Epub 2018 Dec 11.

PMID:
30538297
4.

S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia.

Gianni M, Terao M, Kurosaki M, Paroni G, Brunelli L, Pastorelli R, Zanetti A, Lupi M, Acquavita A, Bolis M, Fratelli M, Rochette-Egly C, Garattini E.

Oncogene. 2019 Apr;38(14):2482-2500. doi: 10.1038/s41388-018-0599-z. Epub 2018 Dec 7.

5.

BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy.

Mio C, Gerratana L, Bolis M, Caponnetto F, Zanello A, Barbina M, Di Loreto C, Garattini E, Damante G, Puglisi F.

Int J Cancer. 2019 Feb 15;144(4):755-766. doi: 10.1002/ijc.31898. Epub 2018 Dec 4.

PMID:
30259975
6.

Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.

Passerini M, Schiavini M, Magni CF, Landonio S, Niero F, Passerini S, Croci AL, Bolis M, Scalzi V, Gubertini G, Ricci ED, Galli M, Rizzardini G.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1208-1215. doi: 10.1097/MEG.0000000000001239.

PMID:
30138160
7.

V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans.

Morelli F, Romeo M, Barzago MM, Bolis M, Mattioni D, Rossi G, Tagliavini F, Bastone A, Salmona M, Diomede L.

Neurobiol Dis. 2018 Sep;117:226-234. doi: 10.1016/j.nbd.2018.06.018. Epub 2018 Jun 22.

PMID:
29936232
8.

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.

Guffanti F, Fratelli M, Ganzinelli M, Bolis M, Ricci F, Bizzaro F, Chilà R, Sina FP, Fruscio R, Lupia M, Cavallaro U, Cappelletti MR, Generali D, Giavazzi R, Damia G.

Oncotarget. 2018 May 15;9(37):24707-24717. doi: 10.18632/oncotarget.25185. eCollection 2018 May 15.

9.

Massive NGS data analysis reveals hundreds of potential novel gene fusions in human cell lines.

Gioiosa S, Bolis M, Flati T, Massini A, Garattini E, Chillemi G, Fratelli M, Castrignanò T.

Gigascience. 2018 Oct 1;7(10). doi: 10.1093/gigascience/giy062.

10.

Generation of a new mouse model of glaucoma characterized by reduced expression of the AP-2β and AP-2δ proteins.

Barzago MM, Kurosaki M, Fratelli M, Bolis M, Giudice C, Nordio L, Cerri E, Domenici L, Terao M, Garattini E.

Sci Rep. 2017 Sep 11;7(1):11140. doi: 10.1038/s41598-017-11752-6.

11.

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.

Cento V, Nguyen THT, Di Carlo D, Biliotti E, Gianserra L, Lenci I, Di Paolo D, Calvaruso V, Teti E, Cerrone M, Romagnoli D, Melis M, Danieli E, Menzaghi B, Polilli E, Siciliano M, Nicolini LA, Di Biagio A, Magni CF, Bolis M, Antonucci FP, Di Maio VC, Alfieri R, Sarmati L, Casalino P, Bernardini S, Micheli V, Rizzardini G, Parruti G, Quirino T, Puoti M, Babudieri S, D'Arminio Monforte A, Andreoni M, Craxì A, Angelico M, Pasquazzi C, Taliani G, Guedj J, Perno CF, Ceccherini-Silberstein F.

PLoS One. 2017 May 18;12(5):e0177352. doi: 10.1371/journal.pone.0177352. eCollection 2017.

12.

Endoplasmic Reticulum Oxidative Stress Triggers Tgf-Beta-Dependent Muscle Dysfunction by Accelerating Ascorbic Acid Turnover.

Pozzer D, Favellato M, Bolis M, Invernizzi RW, Solagna F, Blaauw B, Zito E.

Sci Rep. 2017 Jan 20;7:40993. doi: 10.1038/srep40993.

13.

Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid.

Bolis M, Garattini E, Paroni G, Zanetti A, Kurosaki M, Castrignanò T, Garattini SK, Biancardi F, Barzago MM, Gianni' M, Terao M, Pattini L, Fratelli M.

Ann Oncol. 2017 Mar 1;28(3):611-621. doi: 10.1093/annonc/mdw660.

14.

Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and Ribavirina.

Gentili M, Magni C, Carnovale C, Bolis M, Landonio S, Niero F, Antoniazzi S, Clementi E, Radice S.

Breast J. 2016 Nov;22(6):708-709. doi: 10.1111/tbj.12656. Epub 2016 Aug 4. No abstract available.

PMID:
27488453
15.

Mouse aldehyde-oxidase-4 controls diurnal rhythms, fat deposition and locomotor activity.

Terao M, Barzago MM, Kurosaki M, Fratelli M, Bolis M, Borsotti A, Bigini P, Micotti E, Carli M, Invernizzi RW, Bagnati R, Passoni A, Pastorelli R, Brunelli L, Toschi I, Cesari V, Sanoh S, Garattini E.

Sci Rep. 2016 Jul 26;6:30343. doi: 10.1038/srep30343.

16.

RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.

Gianni M, Fratelli M, Bolis M, Kurosaki M, Zanetti A, Paroni G, Rambaldi A, Borleri G, Rochette-Egly C, Terao M, Garattini E.

Oncotarget. 2017 Jun 6;8(23):37041-37060. doi: 10.18632/oncotarget.10556.

17.

Structure and function of mammalian aldehyde oxidases.

Terao M, Romão MJ, Leimkühler S, Bolis M, Fratelli M, Coelho C, Santos-Silva T, Garattini E.

Arch Toxicol. 2016 Apr;90(4):753-80. doi: 10.1007/s00204-016-1683-1. Epub 2016 Feb 26. Review.

PMID:
26920149
18.

Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.

Garattini E, Bolis M, Gianni' M, Paroni G, Fratelli M, Terao M.

Oncotarget. 2016 Jul 5;7(27):42661-42682. doi: 10.18632/oncotarget.7410. Review.

19.

Model-based Characterization of the Parameters of Dissimilatory Sulfate Reduction Under the Effect of Different Initial Density of Desulfovibrio piger Vib-7 Bacterial Cells.

Kushkevych I, Bolis M, Bartos M.

Open Microbiol J. 2015 Jul 31;9:55-69. doi: 10.2174/1874285801509010055. eCollection 2015.

20.

Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population.

Fratelli M, Bolis M, Kurosaki M, Dori M, Guarnaccia V, Spinelli O, Alberti M, Valoti E, Pileggi S, Noris M, Remuzzi G, Rambaldi A, Terao M, Garattini E.

Leuk Lymphoma. 2016 May;57(5):1234-7. doi: 10.3109/10428194.2015.1082180. Epub 2016 Mar 2. No abstract available.

PMID:
26317246
21.

All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).

Zanetti A, Affatato R, Centritto F, Fratelli M, Kurosaki M, Barzago MM, Bolis M, Terao M, Garattini E, Paroni G.

J Biol Chem. 2015 Jul 17;290(29):17690-709. doi: 10.1074/jbc.M115.638510. Epub 2015 May 27.

22.

MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells.

Fisher JN, Terao M, Fratelli M, Kurosaki M, Paroni G, Zanetti A, Gianni M, Bolis M, Lupi M, Tsykin A, Goodall GJ, Garattini E.

Oncotarget. 2015 May 30;6(15):13176-200.

23.

Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.

Centritto F, Paroni G, Bolis M, Garattini SK, Kurosaki M, Barzago MM, Zanetti A, Fisher JN, Scott MF, Pattini L, Lupi M, Ubezio P, Piccotti F, Zambelli A, Rizzo P, Gianni' M, Fratelli M, Terao M, Garattini E.

EMBO Mol Med. 2015 Jul;7(7):950-72. doi: 10.15252/emmm.201404670.

24.

The four aldehyde oxidases of Drosophila melanogaster have different gene expression patterns and enzyme substrate specificities.

Marelja Z, Dambowsky M, Bolis M, Georgiou ML, Garattini E, Missirlis F, Leimkühler S.

J Exp Biol. 2014 Jun 15;217(Pt 12):2201-11. doi: 10.1242/jeb.102129. Epub 2014 Apr 15.

25.

Retinoids and breast cancer: from basic studies to the clinic and back again.

Garattini E, Bolis M, Garattini SK, Fratelli M, Centritto F, Paroni G, Gianni' M, Zanetti A, Pagani A, Fisher JN, Zambelli A, Terao M.

Cancer Treat Rev. 2014 Jul;40(6):739-49. doi: 10.1016/j.ctrv.2014.01.001. Epub 2014 Jan 18. Review.

PMID:
24480385
26.

[Right-to-health litigation in three Latin American countries: a systematic literature review].

Reveiz L, Chapman E, Torres R, Fitzgerald JF, Mendoza A, Bolis M, Salgado O.

Rev Panam Salud Publica. 2013 Mar;33(3):213-22. Review. Spanish.

PMID:
23698141
27.

Structure and evolution of vertebrate aldehyde oxidases: from gene duplication to gene suppression.

Kurosaki M, Bolis M, Fratelli M, Barzago MM, Pattini L, Perretta G, Terao M, Garattini E.

Cell Mol Life Sci. 2013 May;70(10):1807-30. doi: 10.1007/s00018-012-1229-5. Epub 2012 Dec 21.

PMID:
23263164
28.

[The evolution of the ethnicity/race concept and its impact on framing policies that promote equity].

Torres-Parodi C, Bolis M.

Rev Panam Salud Publica. 2007 Dec;22(6):405-16. Spanish.

PMID:
18291060
29.

[The law and equity in health].

Bolis M.

Rev Panam Salud Publica. 2002 May-Jun;11(5-6):444-8. Review. Spanish.

PMID:
12162844

Supplemental Content

Support Center